Study Stopped
Change in study personnel and sponsor.
Hospice Quality Score Assessment Post Pharmacist Intervention
Assessing the Impact of Pharmacist Interventions on Hospice Quality Scores
1 other identifier
observational
N/A
1 country
1
Brief Summary
The study aims to investigate the impact of pharmacist delivered interventions on hospice patients quality metric scores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2020
CompletedStudy Start
First participant enrolled
April 22, 2020
CompletedFirst Posted
Study publicly available on registry
April 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedSeptember 7, 2022
September 1, 2022
2.4 years
April 22, 2020
September 1, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
National Quality Forum Score
Performance metric used by hospice. Scale 0 - 100 (0=min; 100-high)
6 months
Consumer Assessment of Healthcare Providers and Systems
Performance metric used by hospice (0=min; 100-high)
6 months
Time to refill
Time to refill prescription from hospice organization (0=min; 100-high)
6 months
Study Arms (2)
Intervention
Patients that receive pharmacist-delivered services in the pilot program
Control
Patients that do not receive pharmacist-delivered services in the pilot program
Interventions
Implementation of a medication safety review using a clinical decision support system
Eligibility Criteria
Study population will be hospice population who received services for 6-months (e.g., between April 2020 to October 2020) and information including: age (excluding patients 89 years or older), gender, medication risk score, NQF score, HCAHPS score, time to fill medication order set, type of chronic condition, and number of medications will be studied.
You may qualify if:
- Adult patients who were referred to hospice by a healthcare provider
You may not qualify if:
- Patients 89 years or older
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tabula Rasa HealthCare
Tucson, Arizona, 85701, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Bingham, PharmD
Tabula Rasa HealthCare
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2020
First Posted
April 24, 2020
Study Start
April 22, 2020
Primary Completion
September 1, 2022
Study Completion
September 1, 2022
Last Updated
September 7, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share